Literature DB >> 2148864

Glucosyceramide synthase of mouse kidney: further characterization with an improved assay method.

G S Shukla1, N S Radin.   

Abstract

The synthesis of glucosylceramide from ceramide and UDP-[3H]glucose by mouse kidney homogenates is very sensitive to the concentration of tissue. This was shown to be due to the presence of a UDP-glc pyrophosphatase, which could be blocked by adding NAD to the medium. A new solvent partitioning system is described, containing t-butyl methyl ether, isopropyl alcohol, and aqueous sodium sulfate, which separates the original substrate (UDP-[3H]glc) from the enzyme product, [3H]cerebroside. A particular advantage of the solvent system is that only a single partitioning step is needed, without backwashes, and the enzyme product appears in the upper phase, making transfer to a counting vial more reliable. A novel incubation device, a thermostatically controlled ultrasonic bath, is used to produce highly uniform enzyme reaction rates. Ca2+, as well as Mg2+ and Mn2+, was found to be a good stimulator of the glucosyltransferase. The enzyme activity in kidney of 22-day old mice, approximately 240 pmol/h/mg tissue, is significantly greater than previously demonstrated. The enzyme was stable in intact kidneys stored at -70 degrees C but unstable at 4 degrees C. The enzyme, when acting on endogenous ceramides, showed no demonstrable glucosylation of the C24 family of ceramides although this family is the predominant one in kidney.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2148864     DOI: 10.1016/0003-9861(90)90657-k

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  8 in total

Review 1.  An introduction to plant sphingolipids and a review of recent advances in understanding their metabolism and function.

Authors:  Daniel V Lynch; Teresa M Dunn
Journal:  New Phytol       Date:  2004-01-14       Impact factor: 10.151

Review 2.  Ceramide glycosylation catalyzed by glucosylceramide synthase and cancer drug resistance.

Authors:  Yong-Yu Liu; Ronald A Hill; Yu-Teh Li
Journal:  Adv Cancer Res       Date:  2013       Impact factor: 6.242

3.  P-glycoprotein antagonists confer synergistic sensitivity to short-chain ceramide in human multidrug-resistant cancer cells.

Authors:  Jacqueline V Chapman; Valérie Gouazé-Andersson; Ramin Karimi; Maria C Messner; Myles C Cabot
Journal:  Exp Cell Res       Date:  2011-03-21       Impact factor: 3.905

4.  A role for glycosphingolipid accumulation in the renal hypertrophy of streptozotocin-induced diabetes mellitus.

Authors:  I Z Zador; G D Deshmukh; R Kunkel; K Johnson; N S Radin; J A Shayman
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

5.  Direct quantitative determination of ceramide glycosylation in vivo: a new approach to evaluate cellular enzyme activity of glucosylceramide synthase.

Authors:  Vineet Gupta; Gauri A Patwardhan; Qian-Jin Zhang; Myles C Cabot; S Michal Jazwinski; Yong-Yu Liu
Journal:  J Lipid Res       Date:  2009-10-13       Impact factor: 5.922

6.  Determination of the intracellular sites and topology of glucosylceramide synthesis in rat liver.

Authors:  A H Futerman; R E Pagano
Journal:  Biochem J       Date:  1991-12-01       Impact factor: 3.857

7.  Fluorescence HPLC Analysis of the in-vivo Activity of Glucosylceramide Synthase.

Authors:  Kartik R Roy; Sachin K Khiste; Zhijun Liu; Yong-Yu Liu
Journal:  Bio Protoc       Date:  2019-06-20

8.  Incorporation of Fluorescence Ceramide-Based HPLC Assay for Rapidly and Efficiently Assessing Glucosylceramide Synthase In Vivo.

Authors:  Sachin K Khiste; Salman B Hosain; Yixuan Dong; Mohammad B Uddin; Kartik R Roy; Ronald A Hill; Zhijun Liu; Yong-Yu Liu
Journal:  Sci Rep       Date:  2017-06-07       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.